You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
The attitude of patients with progressive ataxias towards clinical trials
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, January 2022
|
DOI | 10.1186/s13023-021-02091-x |
Pubmed ID | |
Authors |
Gilbert Thomas-Black, Andrada Dumitrascu, Hector Garcia-Moreno, Julie Vallortigara, Julie Greenfield, Barry Hunt, Susan Walther, Mackenzie Wells, David R. Lynch, Hugh Montgomery, Paola Giunti |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 27% |
United States | 3 | 20% |
Germany | 1 | 7% |
Canada | 1 | 7% |
Unknown | 6 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 73% |
Practitioners (doctors, other healthcare professionals) | 3 | 20% |
Scientists | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 18% |
Student > Master | 3 | 11% |
Student > Doctoral Student | 2 | 7% |
Student > Bachelor | 1 | 4% |
Unspecified | 1 | 4% |
Other | 2 | 7% |
Unknown | 14 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Social Sciences | 2 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
Neuroscience | 2 | 7% |
Medicine and Dentistry | 2 | 7% |
Other | 4 | 14% |
Unknown | 14 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2023.
All research outputs
#2,942,913
of 23,773,220 outputs
Outputs from Orphanet Journal of Rare Diseases
#414
of 2,747 outputs
Outputs of similar age
#71,386
of 515,660 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#11
of 97 outputs
Altmetric has tracked 23,773,220 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,747 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,660 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.